{"title":"迫在眉睫的细胞技术人员短缺。","authors":"D. Johnson","doi":"10.2307/4594438","DOIUrl":null,"url":null,"abstract":"At the very time when the Administration is pressing for an increase of $100 million in Federal expenditures for the conquest of cancer, a shortage of cytotechnologists, who are valuable in research as well as control, may occur. When Congress passed the Partnership for Health Act and section 314E became effective in June 1970, cancer was among the categorical diseases that lost Federal support for control activities. The Cancer Control Program, which was funding 78 training programs in cytotechnology, ended.","PeriodicalId":78306,"journal":{"name":"HSMHA health reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1972-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2307/4594438","citationCount":"1","resultStr":"{\"title\":\"Impending shortage of cytotechnologists.\",\"authors\":\"D. Johnson\",\"doi\":\"10.2307/4594438\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"At the very time when the Administration is pressing for an increase of $100 million in Federal expenditures for the conquest of cancer, a shortage of cytotechnologists, who are valuable in research as well as control, may occur. When Congress passed the Partnership for Health Act and section 314E became effective in June 1970, cancer was among the categorical diseases that lost Federal support for control activities. The Cancer Control Program, which was funding 78 training programs in cytotechnology, ended.\",\"PeriodicalId\":78306,\"journal\":{\"name\":\"HSMHA health reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1972-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2307/4594438\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HSMHA health reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2307/4594438\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HSMHA health reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2307/4594438","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
就在政府迫切要求增加1亿美元的联邦开支用于战胜癌症的时候，可能会出现细胞技术专家的短缺，而细胞技术专家在研究和控制方面都很有价值。1970年6月，国会通过了《健康合作法案》(Partnership for Health Act)，第314E条开始生效。当时，癌症是失去联邦政府控制活动支持的一类疾病之一。资助78个细胞技术培训项目的癌症控制项目结束了。
At the very time when the Administration is pressing for an increase of $100 million in Federal expenditures for the conquest of cancer, a shortage of cytotechnologists, who are valuable in research as well as control, may occur. When Congress passed the Partnership for Health Act and section 314E became effective in June 1970, cancer was among the categorical diseases that lost Federal support for control activities. The Cancer Control Program, which was funding 78 training programs in cytotechnology, ended.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
